Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial

Overview of attention for article published in Neurology, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs: 1 blog
twitter: 12 X users

facebook: 2 Facebook pages

Readers on

mendeley: 149 Mendeley

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 116,670 followers.

Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial https://t.co/leLuiACz98

RT @JeffHeadacheCtr: Acetazolamide improves quality of life measures in Idiopathic Intracranial Hypertension despite risk of side effects.…

Acetazolamide improves quality of life measures in Idiopathic Intracranial Hypertension despite risk of side effects. https://t.co/ahxnFFRGZr

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.